About Us
Mergenet Medical, Inc. is an
innovative, technology-driven medical device company that develops and
commercializes products for treatment of sleep disordered breathing,
respiratory insufficiency and other respiratory disorders. Since it began
operations, the company has been focused on developing its revolutionary
High Flow Therapy (HfT) device that is able to deliver heated humidified air
through a nasal cannula to patients at high flow rates, without the need for
a sealing interface.
The HfT device is initially intended to be directed toward the critical care market, as high flow, heated humidified air has been shown to significantly increase blood oxygen concentrations without the need for invasive interventions.
High flow therapy can be used in treatments relating to asthma, chronic obstructive pulmonary disease, congestive heart failure, emphysema, and post operative recoveries.
Mergenet
Medical will sell its devices in both the homecare and critical care
markets. The critical care market includes hospitals, alternative care
facilities and emergency medical settings. Airway interfaces distributed to
the critical care market are intended to be single or limited use disposable
items designed to reduce the need for invasive interventions, such as
endotracheal intubations and tracheotomies. Health care providers and
insurance companies have a strong preference to minimize invasive
interventions, as they are linked to higher rates of ventilator associated
infection (such as Pneumonia), which can potentially increase mortality
rates and cost.